Imaging of hypoxia with [18F] fluoromisonidazole for cure limitation tissue and therapy strategy

Imaging of hypoxia with [18F] fluoromisonidazole for cure limitation tissue and therapy strategy - FMISO-PET/CT clinical study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002652

Enrollment

Registered

2009-11-01

Start date

2009-11-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, Breast cancer, Colon cancer, Head and neck cancer, Brain tumor, Pancreatic cancer, Malignant lymphoma, Malignant melanoma, Esophageal cancer, Endometrial cancer,uterine cervical cancer, ovarian cancer

Interventions

FMISO-PET/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Pregnancy or possibility of pregnancy Patients regarded as unsuitable by responsible investigators

Design outcomes

Primary

Measure	Time frame
Tracer uptake in biphasic pairs of [18F]FMISO-PET/CT and [18F]FDG-PET/CT	—

Countries

Japan

Contacts

Public ContactClinical test assistant

Saitama Medical University International Medical Center Clinical test assistant center

chikens@saitama-med.ac.jp042-984-4111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026